Back to News
research

RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years

Seeking Alpha
Loading...
3 min read
0 likes
⚡ Quantum Brief
RenaissanceRe’s preferred stock dividends remain highly secure, requiring under 1.5% of net income for payouts, signaling strong financial health and dividend sustainability. The company holds nearly $11 billion in common equity, providing a robust cushion that enhances the safety of preferred shares against market volatility. Series F preferred shares offer a 6.75% yield and are likely to be called before Series G due to their higher cost of capital, making them a strategic short-term investment. Despite being non-cumulative, the preferred stocks present an attractive risk-reward balance, backed by solid asset coverage and consistent earnings. Analysts highlight the appeal of these shares for income-focused investors, emphasizing their stability and potential for steady returns in the current market.
AI Audio Summary
0:00 / 0:00
Click to play
pexels-thisisengineering-3861969 (1).jpg
Quantum News · Media Library

The Investment DoctorInvesting Group LeaderFollow5ShareSavePlay(6min)CommentsSummaryRenaissanceRe (RNR) preferred dividends remain exceptionally well-covered, requiring less than 1.5% of attributable net income for payout.RNR boasts nearly $11B in common equity as a substantial cushion, enhancing preferred stock safety.The Series F preferred shares yield 6.75% and are likely to be called before Series G due to higher cost of capital.Despite non-cumulative status, RNR preferreds offer an attractive risk-reward profile given robust coverage and asset backing.Looking for more investing ideas like this one? Get them exclusively at European Small-Cap Ideas. Learn More » designer491/iStock via Getty Images Introduction As it has been approximately 2 years since I last had a look at RenaissanceRe (RNR) and its preferred shares, I wanted to see if the recently filed annual report still indicates the preferred dividends areThis article was written byThe Investment Doctor23.71K FollowersFollowThe Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks. He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital gains and dividend income for continuous cash flow. Features include: two model portfolios - the European Small Cap Ideas portfolio and the European REIT Portfolio, weekly updates, educational content to learn more about the European investing opportunities, and an active chat room to discuss the latest developments of the portfolio holdings. Learn more.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. I may initiate a long position in the preferred stock, but this is unlikely to happen in the next 72 hours.Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read Original

Tags

quantum-investment

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.